Joseph Ciaffoni, President and CEO at COLLEGIUM PHARMACEUTICAL, INC (COLL), sold 125,086 shares at $21.90 ($2.7M) on 2023-05-30, disclosed to the SEC on 2023-06-01.
Scheduled sale ($2.7M) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.90 | 31,271 | $685K | 25.0% |
| 2 | $21.90 | 31,271 | $685K | 25.0% |
| 3 | $21.87 | 31,272 | $684K | 25.0% |
| 4 | $21.87 | 31,272 | $684K | 25.0% |
| Total | $21.89 avg | 125,086 | $2.7M | 100% |
| Filing → |
| COLL | SELL | 2023-06-02 | $2.7M | — | Filing → |
| COLL | SELL | 2023-02-14 | $302K | — | Filing → |
| COLL | SELL | 2022-12-27 | $58K | — | Filing → |